CN118215505A - 双环肽配体药物偶联物 - Google Patents

双环肽配体药物偶联物 Download PDF

Info

Publication number
CN118215505A
CN118215505A CN202280074636.3A CN202280074636A CN118215505A CN 118215505 A CN118215505 A CN 118215505A CN 202280074636 A CN202280074636 A CN 202280074636A CN 118215505 A CN118215505 A CN 118215505A
Authority
CN
China
Prior art keywords
drug conjugate
acid
peptide
peptide ligand
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280074636.3A
Other languages
English (en)
Chinese (zh)
Inventor
P·贝斯维克
G·穆德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
BicycleTx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleTx Ltd filed Critical BicycleTx Ltd
Publication of CN118215505A publication Critical patent/CN118215505A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN202280074636.3A 2021-10-06 2022-10-06 双环肽配体药物偶联物 Pending CN118215505A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2114279.9A GB202114279D0 (en) 2021-10-06 2021-10-06 Bicyclic peptide ligand drug conjugates
GB2114279.9 2021-10-06
PCT/GB2022/052524 WO2023057758A1 (en) 2021-10-06 2022-10-06 Bicyclic peptide ligand drug conjugates

Publications (1)

Publication Number Publication Date
CN118215505A true CN118215505A (zh) 2024-06-18

Family

ID=78497713

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280074636.3A Pending CN118215505A (zh) 2021-10-06 2022-10-06 双环肽配体药物偶联物

Country Status (6)

Country Link
US (1) US20240398965A1 (https=)
EP (1) EP4412657A1 (https=)
JP (1) JP2024536413A (https=)
CN (1) CN118215505A (https=)
GB (1) GB202114279D0 (https=)
WO (1) WO2023057758A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
IL279489B2 (en) * 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201914872D0 (en) * 2019-10-15 2019-11-27 Bicycletx Ltd Bicyclic peptide ligand drug conjugates

Also Published As

Publication number Publication date
JP2024536413A (ja) 2024-10-04
US20240398965A1 (en) 2024-12-05
EP4412657A1 (en) 2024-08-14
GB202114279D0 (en) 2021-11-17
WO2023057758A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
CN111741771B (zh) 特异于epha2的双环肽配体
CN114521197B (zh) 异串联双环肽复合物
CN114901317A (zh) 双环肽配体药物偶联物
CN111183147B (zh) Cd137特异性的双环肽配体
EP3452096B1 (en) Bicyclic peptide-toxin conjugates specific for mt1-mmp
CN107148425B (zh) 对mt1-mmp特异性的双环肽配体
US20220306689A9 (en) Bicyclic peptide ligands specific for pd-l1
CN113543813B (zh) Cd38特异性的双环肽配体
CN113383007A (zh) Caix特异性的双环肽配体
CN113260420A (zh) Pd-l1特异性的双环肽配体
CN113507960A (zh) Psma特异性的双环肽配体
CN118215505A (zh) 双环肽配体药物偶联物
CN114787177A (zh) Il-17特异性的双环肽配体
CN118234517A (zh) 双环肽配体药物偶联物
RU2824959C2 (ru) Бициклические пептидные лиганды, специфичные для mt1-mmp
CN114787176A (zh) Il-17特异性的双环肽配体

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination